HPLC specific chromatograms of Poria were established, and the concentrations of 10 triterpenoids(16α-hydroxydehydrotrametenolic acid, poricoic acid B, dehydrotumulosic acid, poricoic acid A, polyporenic acid C, poricoic acid AM, 3-O-acetyl-16α-hydroxydehydrotrametenolic acid, dehydropachymic acid, pachymic acid, and dehydrotrametenolic acid) were simultaneously determined. Chromatographic analysis was conducted on a Welch Ultimate XB C_(18) column(4.6 mm × 250 mm,5 μm). Acetonitrile solution(contain 3% tetrahydrofuran)(A) and 0.1% formic acid aqueous solution(B) were used as the mobile phase with gradient elution at a flow rate of 1.0 mL·min~(-1). The column temperature was 30 ℃ and the injection volume was 20 μL. The experimental data were analyzed by the SPSS 22.0 and GraphPad Prism 7.0. The established triterpenoids fingerprints were specific, and the 10 components were well separated and showed good linearity(r≥0.999 6) within the concentration ranges tested. The mean recoveries were between 98.53%-103.8%(RSD 1.7%-2.7%). The method was specific and repeatable, and could be used for identification and quality evaluation of Poria. The results showed that the contents of 10 triterpenoids were positively correlated with each other. The contents of 10 triterpenoids of samples collected from producing areas were higher than that collected from markets. The total contents of 10 triterpenoids of samples collected from Hubei and Yunnan province were slightly higher than that from Anhui province, but the contents of samples from Anhui province were varied in smaller ranges.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20181220.005DOI Listing

Publication Analysis

Top Keywords

acid poricoic
12
poricoic acid
12
contents triterpenoids
12
acid
11
evaluation poria
8
triterpenoids samples
8
samples collected
8
anhui province
8
[quality evaluation
4
poria based
4

Similar Publications

Poricoic acid A attenuates renal fibrosis by inhibiting endoplasmic reticulum stress-mediated apoptosis.

Braz J Med Biol Res

November 2024

Clinical Experimental Center, Xi'an Engineering Technology Research Center for Cardiovascular Active Peptides, Northwest University Affiliated Xi'an International Medical Center Hospital, Xi'an, Shaanxi, China.

Article Synopsis
  • Renal fibrosis is a key issue in chronic kidney disease leading to kidney failure, and there are currently no therapies to stop its progression.
  • A study found that Poricoic acid A (PAA), derived from Poria cocos, effectively reduces renal damage and collagen buildup in a mouse model of renal fibrosis caused by unilateral ureteral obstruction.
  • PAA works by inhibiting processes like epithelial-to-mesenchymal transition (EMT) and endoplasmic reticulum stress (ERS), as well as reducing apoptosis in kidney cells, indicating its potential as a treatment for renal fibrosis.
View Article and Find Full Text PDF

Background: Poricoic acid A (PAA), a major triterpenoid component of Poria cocos with anti-tumor, anti-fibrotic, anti-inflammatory, and immune-regulating activities, has been shown to induce podocyte autophagy in diabetic kidney disease (DKD) by downregulating FUN14 domain containing 1 (FUNDC1). This study aimed to identify the role of adenosine monophosphate-activated protein kinase alpha (AMPKα) in PAA-mediated phosphorylation of FUNDC1 in podocyte injury occurring in the pathogenesis of DKD.

Methods And Results: A cellular model of renal podocyte injury was established by culturing MPC5 cells under high-glucose (HG) conditions.

View Article and Find Full Text PDF

Background And Objectives: Diabetic cardiomyopathy (DCM) is a cardiac condition resulting from myocardial damage caused by diabetes mellitus (DM), currently lacking specific therapeutic interventions. Fuzhengkangfu decoction (FZK) plays an important role in the prevention and treatment of various cardiovascular diseases. However, the efficacy and potential mechanisms of FZK are not fully understood.

View Article and Find Full Text PDF

The proprietary Chinese medicine Jinkui Shenqi Pill (PCM-JKSQP) is a classic compound used for the effective clinical treatment of kidney yang deficiency syndrome (KYDS), a metabolic disease accompanied by kidney injury. However, its active ingredients and therapeutic mechanisms are not clear. This study employed serum pharmacochemistry, network pharmacology, and pharmacokinetics (PK) to identify the bioactive components of PCM-JKSQP and preliminarily clarify its mechanism in treating KYDS.

View Article and Find Full Text PDF
Article Synopsis
  • * The research found that PAA treatment improved cell proliferation and reduced apoptosis in human cardiac microvascular endothelial cells (HCMECs) subjected to oxygen glucose deprivation, simulating MI.
  • * PAA was shown to enhance autophagy, promote angiogenesis, and activate the AMPK/mTOR signaling pathway, suggesting its potential as a therapeutic agent for MI recovery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!